HealthEquity, Inc.

HealthEquity, Inc. (HQY) Market Cap

HealthEquity, Inc. has a market capitalization of $7.35B.

Financials based on reported quarter end 2026-01-31

Price: $86.04

โ–ฒ 1.51 (1.79%)

Market Cap: 7.35B

NASDAQ ยท time unavailable

CEO: Scott R. Cutler

Sector: Healthcare

Industry: Medical - Healthcare Information Services

IPO Date: 2014-07-31

Website: https://www.healthequity.com

HealthEquity, Inc. (HQY) - Company Information

Market Cap: 7.35B ยท Sector: Healthcare

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.

Analyst Sentiment

82%
Strong Buy

Based on 16 ratings

Analyst 1Y Forecast: $111.07

Average target (based on 4 sources)

Consensus Price Target

Low

$89

Median

$110

High

$125

Average

$110

Potential Upside: 27.7%

Price & Moving Averages

Loading chart...

๐Ÿ“˜ Full Research Report

โ„น๏ธ

AI-Generated Research: This report is for informational purposes only.

๐Ÿ“˜ HEALTHEQUITY INC (HQY) โ€” Investment Overview

๐Ÿงฉ Business Model Overview

HealthEquity, Inc. (HQY) is a leading provider of technology-enabled services focused primarily on empowering consumers to manage health care savings and spending. The companyโ€™s core business centers on Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), Health Reimbursement Arrangements (HRAs), and other consumer-directed health benefit solutions that facilitate a shift from traditional employer- and insurer-controlled health spending to individual-managed accounts. HealthEquity operates as a custodian of these accounts, while also leveraging a highly integrated ecosystem of partners, including employers, benefits advisors, health plans, and managed care organizations. HealthEquityโ€™s value proposition centers on simplifying health account administration, offering digital-first engagement, best-in-class platform architecture, and an omni-channel member support system. Through its cloud-based technology platform, HealthEquity delivers seamless account opening, financial transaction support, investment options, and educational guidance to millions of individual members, with a nationwide footprint and diversified client base.

๐Ÿ’ฐ Revenue Streams & Monetisation Model

HealthEquityโ€™s revenue streams are diversified across three primary categories: 1. **Service Revenue:** Generated from account administration and maintenance fees, onboarding and engagement services, employer/plan sponsor solutions, and custom platform integrations. 2. **Custodial Revenue:** Derived from interest earned on custodial cash deposits held in HSAs and related accounts, as well as from fees associated with facilitating investment of HSA balances in mutual funds and other vehicles. 3. **Interchange Revenue:** Collected from card transactions when members use HealthEquity-issued debit payment cards for qualified health expenditures, typically as a percentage of transaction value. The companyโ€™s monetisation model is characterized by recurring fee-based income streams, with significant operating leverage as account volumes expand. Additional monetisation occurs via cross-selling higher-value services, such as COBRA administration and commuter benefits, to existing clients. HealthEquity also benefits from scale-driven advantages in both net interest margin on custodial balances and issuer-provided interchange economics.

๐Ÿง  Competitive Advantages & Market Positioning

HealthEquity commands a leading market share in the HSA provider category, benefiting from multiple durable competitive advantages: - **Integrated Platform:** HealthEquityโ€™s unified technology stack streamlines administration for both account holders and sponsors, reducing friction and increasing user engagement. - **Scale and Brand:** As one of the largest non-bank custodians of consumer health accounts, HealthEquity enjoys both brand recognition and a broad set of distribution relationships with employers and health plans. - **Cross-Selling Opportunities:** The platform approach allows HealthEquity to deliver a full suite of consumer-directed health and benefit products, deepening client stickiness and creating embedded switching costs. - **Data Analytics and Member Engagement:** HealthEquity leverages proprietary data analytics to drive tailored plan recommendations, education, and proactive engagement. This increases account utilization and supports sustained asset growth. - **Regulatory Compliance Expertise:** Operating in a complex, highly regulated segment, HealthEquity maintains compliance infrastructure and expertise that represent significant barriers to smaller or newer entrants.

๐Ÿš€ Multi-Year Growth Drivers

Several structural and company-specific factors underpin HealthEquityโ€™s multi-year growth outlook: - **Expansion of Consumer-Directed Health Plans (CDHPs):** Ongoing healthcare cost inflation continues to drive migration from traditional insurance plans to high-deductible health plans (HDHPs), turbocharging HSA adoption among both employers and individual consumers. - **Rising HSA Penetration and Contribution Levels:** Although HSA penetration is increasing, the addressable market remains far from maturity, with opportunity for higher account balances, broader investment of HSA assets, and increased utilization of ancillary services over time. - **Strategic M&A:** HealthEquity complements organic growth with targeted acquisitions, enabling the company to add member accounts, enter new verticals, and capture operational synergies, leveraging a scalable technology backbone. - **Interest Rate Environment:** Higher interest rates can materially increase custodial revenue from holding HSA cash balances, causing elevated net interest income without commensurate increases in operating cost. - **Digital Engagement and Solution Expansion:** Ongoing investments in user experience, APIs, and integration with benefit platforms strengthen the value proposition to employers and members, supporting further wallet share capture.

โš  Risk Factors to Monitor

Investors should remain vigilant regarding several key risks: - **Regulatory Uncertainty:** The company is significantly affected by changes in health care and tax legislation, regulations impacting HSA eligibility, contribution limits, or tax treatment, and potential shifts in federal or state-level healthcare policy. - **Interest Rate Volatility:** Earnings from custodial cash balances are sensitive to market interest rates. A downward move in rates or curve flattening could pressure custodial revenue. - **Competitive Pressures:** The HSA and consumer-directed benefits market continues to attract large financial institutions, fintechs, and traditional payroll processors, raising concerns around fee compression, service commoditization, and contract renewals. - **Data Security and Privacy:** As a custodian of sensitive financial and health data, HealthEquity is exposed to cybersecurity, data breach, and privacy risks that could entail reputational harm or regulatory penalties. - **Integration Risk:** Acquisition-driven growth introduces potential for integration challenges, customer attrition, or unforeseen operational complexities that could impede synergy realization.

๐Ÿ“Š Valuation & Market View

HealthEquity is typically valued at a premium to traditional financial institutions, reflecting its technology-driven growth profile, recurring revenue model, and expanding addressable market. Market participants often benchmark HQY using enterprise value-to-EBITDA and price-to-earnings multiples relative to other fintech-enabled benefit administrators and asset-light custodial businesses. Investors consider the companyโ€™s historical ability to deliver mid-to-high-teens revenue growth, robust adjusted EBITDA margins, and steady account expansion as supportive of premium valuation. Furthermore, market sentiment often tracks HSA adoption trends, regulatory tailwinds, and the interest rate environment, given their direct earnings impact. Growth investors are drawn to HQYโ€™s durable mix of fee-based and interest income, strong operating leverage, and ongoing expansion into adjacent benefit offerings. At the same time, valuation sensitivity remains high around regulatory or macroeconomic shifts, which could materially influence custodial spread or structural HSA demand.

๐Ÿ” Investment Takeaway

HealthEquity occupies a unique position at the intersection of healthcare, fintech, and benefit administration, offering investors exposure to durable secular trends in consumer-driven healthcare, digital benefit management, and recurring platform-based revenue. The companyโ€™s scale, technology, and regulatory expertise support defensible market share and recurring margins, while its expanding suite of benefit solutions creates compelling long-term growth optionality. While the company faces competition from larger incumbents and regulatory uncertainty, its robust balance sheet, operational discipline, and integrated service delivery position HQY favorably for compound growth. For investors seeking exposure to the intersection of healthcare savings, fintech, and digital engagement, HealthEquity represents a leading player with credible multi-year growth prospects, albeit with risks tied to regulation, interest rates, and competition that merit active monitoring.

โš  AI-generated โ€” informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

๐Ÿ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-01-31

"For the fiscal year ending January 31, 2026, HQY reported revenue of $334.6M and a net income of $49.7M, resulting in an earnings per share (EPS) of $0.58. The company has a healthy balance sheet, with total assets of $3.38B and total liabilities of approximately $1.12B, leading to total equity of about $2.11B. Importantly, HQY has negative net debt of $274.8M, indicating a robust liquidity position. Despite these strengths, HQY has faced stock price challenges, with the share price declining by 9.10% over the past year and 9.85% year-to-date. There were no dividends paid out during this period, and while free cash flow stands at $101.5M, the lack of price appreciation could be a concern for investors. The price targets range from $85 to $125, reflecting a mixed sentiment from analysts. Overall, while the fundamentals present a sturdy financial posture, recent market performance signals the need for careful consideration."

Revenue Growth

Neutral

The revenue growth of 334.6M indicates positive growth, though specific growth rates were not provided.

Profitability

Positive

The net income of 49.7M shows a reasonable profit margin, reflecting solid operational efficiency.

Cash Flow Quality

Positive

Free cash flow of 101.5M is strong, providing financial flexibility.

Leverage & Balance Sheet

Strong

A strong balance sheet with negative net debt indicates low financial risk.

Shareholder Returns

Caution

With a 1-year price decline and no dividends, shareholder returns are limited.

Analyst Sentiment & Valuation

Neutral

Analysts have varied price targets, indicating uncertainty in market sentiment.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

HealthEquity delivered strong Q4 and FY26 results with record HSA sales, double-digit HSA asset growth, and substantial margin expansion. Security and AI investments reduced fraud and lowered cost to serve, while new marketplace and retail HSA initiatives broadened growth channels. Capital returns were robust through significant buybacks, and interest-rate hedges help stabilize custodial yields. With constructive policy tailwinds and a raised FY27 outlook, managementโ€™s tone was confident, though they acknowledge rate, regulatory, and execution risks.

Growth

  • Added ~550,000 HSAs in Q4; >1.0M new HSAs from sales in FY26; total accounts reached 17.8M
  • HSA assets exceeded $36B, up 14% YoY; asset growth outpaced account growth
  • Q4 adjusted EBITDA of $132.9M, up 23% YoY; adjusted EBITDA margin expanded >500 bps to 40%
  • Q4 revenue of $334.6M, up 7% YoY; custodial revenue +12%, service +2%, interchange +6%
  • HSA investors grew 10% YoY; invested assets now >50% of total HSA assets

Business Development

  • Launched HealthEquity marketplace (weight-loss programs, hormone therapy, wearables) with encouraging early retention
  • Expanded direct-to-consumer HSA enrollment for ACA bronze plan members, opening a new retail healthcare channel
  • Mobile engagement scaling with 3.6M app downloads; improved card authorization performance
  • Introduced passkey authentication to simplify access and enhance security
  • Maintained broad distribution: >200 network partners and >100,000 employer clients
  • More merchants highlighting HSA/FSA eligibility at checkout to drive conversions

Financials

  • Q4 gross profit $228.1M; gross margin 68% (+700 bps YoY); service costs down $17M YoY as fraud reimbursements fell to ~$0.3M
  • Q4 GAAP net income $49.7M ($0.58/sh); non-GAAP net income $81.8M ($0.95/sh; NI +33%, EPS +38%)
  • FY26 revenue $1.313B (+9.5% YoY); GAAP net income $215.2M ($2.46/sh) with 16% net margin
  • FY26 adjusted EBITDA $566M (+20% YoY), 43% margin; operating cash flow $457M
  • HSA cash average yield 3.53% in FY26; Q4 annualized yield 3.57%; 58% of HSA cash in enhanced-rate contracts

Capital & Funding

  • Repurchased >$300M of shares in FY26 (โ‰ˆ$82M in Q4), reducing diluted shares outstanding by ~3%; $178M authorization remaining
  • Ended Q4 with $319M cash and ~$957M debt; paid down $25M on revolver in the quarter
  • Interest-rate hedging in place: $2.4B notional U.S. Treasury forwards, blended lock 3.92% for maturities Mar 2026โ€“Jan 2028; expect additional hedges
  • Expect FY27 average HSA cash yield of ~3.8%

Operations & Strategy

  • Embedding AI to elevate member support (HSA Answers, HealthEquity Assist, expedited claims), automate service, and personalize guidance
  • Security focus reduced fraud costs to ~1.1 bps for FY26; Q4 exit run-rate ~0.1 bps; top percentile performance in Visa network
  • Platform spans HSAs, FSAs, and commuter benefits to provide single-admin solution for employers
  • Leveraging cohort maturation and distribution scale for operating leverage; targeting a fourth consecutive year in the Rule of 50

Market & Outlook

  • Policy tailwinds: Working Families Tax Cut Act enables HSAs for ACA bronze plans; additional pro-HSA proposals advancing
  • Secular shift toward consumer-directed healthcare and digital-first experiences supports adoption
  • Industry backdrop: >$40B spent from HSAs and >$55B contributed last year, growing balances
  • Management raised FY27 outlook (specifics not disclosed in excerpt) and targets continued Rule of 50 performance; anticipates ~3.8% average HSA cash yield in FY27

Risks Or Headwinds

  • Interest rate volatility could impact custodial yields despite hedging
  • Cybersecurity and fraud remain ongoing risks requiring continued investment
  • Execution risk in scaling AI capabilities, marketplace offerings, and retail HSA channel
  • Potential regulatory changes could affect HSA eligibility or economics
  • Macroeconomic and employment trends may influence account growth and spend

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the HQY Q4 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
๐Ÿ“

SEC Filings (HQY)

ยฉ 2026 Stock Market Info โ€” HealthEquity, Inc. (HQY) Financial Profile